[Efficacy and safety of rh-endostatin combined with docetaxel in second-line or intolerant toxicity for first-line treatment in patients with advanced non-small cell lung cancer].

Jing Wang, Kai Li, Tong Sun, Ming jun Zhang, Wei lian Li, Qiang Yao, Wei Liu, Cui min Ding, Zhi yong He, Wei dong Mao, Hui min Wang, Y. Zhang, Xin li Zhou

    Research output: Contribution to journalArticle

    3 Scopus citations

    Fingerprint Dive into the research topics of '[Efficacy and safety of rh-endostatin combined with docetaxel in second-line or intolerant toxicity for first-line treatment in patients with advanced non-small cell lung cancer].'. Together they form a unique fingerprint.

    Medicine & Life Sciences